Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Restless Leg Syndrome

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
794
mi
from 43215
Spring Hill, FL
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
794
mi
from 43215
Spring Hill, FL
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
806
mi
from 43215
Destrehan, LA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
806
mi
from 43215
Destrehan, LA
Click here to add this to my saved trials
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Status: Enrolling
Updated:  2/23/2016
Yale Physcian Building
536
mi
from 43215
New Haven, CT
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Status: Enrolling
Updated: 2/23/2016
Yale Physcian Building
536
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Sleep Disorders Management, Health and Safety in Police
Sleep Disorders Management, Health and Safety in Police
Status: Enrolling
Updated:  3/15/2016
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Sleep Disorders Management, Health and Safety in Police
Sleep Disorders Management, Health and Safety in Police
Status: Enrolling
Updated: 3/15/2016
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated:  3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
643
mi
from 43215
Boston, MA
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated: 3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Status: Enrolling
Updated:  6/28/2016
University of South Florida
822
mi
from 43215
Tampa, FL
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Status: Enrolling
Updated: 6/28/2016
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome
Status: Enrolling
Updated:  7/12/2016
Kyowa Pharmaceutical Inc.
441
mi
from 43215
Princeton, NJ
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome
Status: Enrolling
Updated: 7/12/2016
Kyowa Pharmaceutical Inc.
441
mi
from 43215
Princeton, NJ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1669
mi
from 43215
Sun City, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1669
mi
from 43215
Sun City, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1953
mi
from 43215
Anaheim, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1953
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
2107
mi
from 43215
Burlingame, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
2107
mi
from 43215
Burlingame, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1967
mi
from 43215
Newport Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1967
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1965
mi
from 43215
Pasadena, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1965
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1985
mi
from 43215
Redondo Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1985
mi
from 43215
Redondo Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1984
mi
from 43215
Santa Monica, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1984
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
2101
mi
from 43215
Stanford, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1985
mi
from 43215
Winnetka, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1985
mi
from 43215
Winnetka, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
955
mi
from 43215
Boca Raton, FL
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1749
mi
from 43215
Coeur d'Alene, ID
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1749
mi
from 43215
Coeur d'Alene, ID
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
562
mi
from 43215
Springfield, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
562
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
677
mi
from 43215
West Yarmouth, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
677
mi
from 43215
West Yarmouth, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
607
mi
from 43215
Worcester, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
607
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
209
mi
from 43215
Kalamazoo, MI
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
209
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
617
mi
from 43215
St. Paul, MN
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
617
mi
from 43215
St. Paul, MN
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
397
mi
from 43215
St. Louis, MO
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
1759
mi
from 43215
Las Vegas, NV
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
1759
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
514
mi
from 43215
Albany, NY
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
514
mi
from 43215
Albany, NY
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
462
mi
from 43215
Tabor City, NC
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
462
mi
from 43215
Tabor City, NC
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
857
mi
from 43215
Fargo, ND
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
857
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
618
mi
from 43215
Warwick, RI
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
618
mi
from 43215
Warwick, RI
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
590
mi
from 43215
Burlington, VT
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
9459
mi
from 43215
Camperdown,
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
9459
mi
from 43215
Camperdown,
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
509
mi
from 43215
Alabaster, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
509
mi
from 43215
Alabaster, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
484
mi
from 43215
Jasper, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
484
mi
from 43215
Jasper, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1644
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1669
mi
from 43215
Sun City, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1669
mi
from 43215
Sun City, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1955
mi
from 43215
Laguna Hills, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1955
mi
from 43215
Laguna Hills, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1981
mi
from 43215
Northridge, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1981
mi
from 43215
Northridge, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
2017
mi
from 43215
Oxnard, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
2017
mi
from 43215
Oxnard, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1965
mi
from 43215
Pasadena, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1965
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1985
mi
from 43215
Redondo Beach, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1985
mi
from 43215
Redondo Beach, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1980
mi
from 43215
Reseda, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1980
mi
from 43215
Reseda, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
1948
mi
from 43215
San Diego, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
1948
mi
from 43215
San Diego, CA
Click here to add this to my saved trials